Literature DB >> 3025993

Immunosuppression in viral infections.

B T Rouse, D W Horohov.   

Abstract

Viruses may cause immunosuppression by a variety of mechanisms. This review delineates four categories. First, immunosuppression can result from the direct effects of viral replication on lymphocyte functions. Either all classes of lymphocytes can be affected, as occurs in measles, or the effect can be restricted to a cell subtype, as is the case with human T cell-lymphotropic virus type III. Second, the activity of soluble factors of viral or host origin released from infected cells can affect immunosuppression. A third mechanism results from viral infection of macrophages and affects the function of these cells in natural and acquired immunity. Finally, immunosuppression may result from viral triggering of an imbalance in immune regulation, which culminates in the overactivity of suppressor cells. A detailed knowledge of the mechanisms by which viruses are involved in immunosuppression may help in the design of strategies to reverse the effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025993     DOI: 10.1093/clinids/8.6.850

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  40 in total

1.  Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Authors:  J P Vestey; M Norval; S Howie; J Maingay; W A Neill
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

Review 2.  The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer.

Authors:  Frances Mercer; Derya Unutmaz
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  The role of CD4+ lymphocytes in the activation of non-specific suppressor cells by antigen.

Authors:  H Stefanovic; C Izaguirre; L G Filion
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

4.  Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice.

Authors:  B L Lohman; R M Welsh
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes.

Authors:  M F Saron; B Shidani; M A Nahori; J C Guillon; P Truffa-Bachi
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  The effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man.

Authors:  D S Halvorsen; J B Hansen; S Grimsgaard; K H Bønaa; P Kierulf; A Nordøy
Journal:  Lipids       Date:  1997-09       Impact factor: 1.880

7.  Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status.

Authors:  G Schmidt; K Amiraian; H Frey; R W Stevens; D S Berns
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

8.  Replication of human cytomegalovirus in the cells of the U937 monocytoid cell line.

Authors:  K Numazaki; N Nagata; T Sato; S Chiba
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  In vivo modulation of natural killer cell activity by tamoxifen in patients with bilateral primary breast cancer.

Authors:  E Robinson; D Rubin; T Mekori; R Segal; S Pollack
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.